SVP of Finance Sandra Gurrola resigns, effective July 3, 2026

Ernexa Therapeutics Inc.

Sandra Gurrola, SVP of Finance, resigned June 22, 2026, effective July 3, 2026.
Resignation not due to any disagreement with the Company's operations, policies, or practices.
Gurrola will provide part-time transition assistance (up to 10 hrs/week) through Q2 2026 10-Q filing.
Company has initiated search for a successor and will use outside support for finance, accounting, and reporting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.